Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Filings indexed 1,223 across all filing types
Latest filing 2009-04-22 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings
2009-04-22 English
Regulatory Filings 2009
Regulatory Filings
2009-04-16 English
Immediate Report
Delisting Announcement Classification · 100% confidence The document is a press release announcing that XTL Biopharmaceuticals Ltd. has received a notification from the Nasdaq Listing Qualifications Panel that its American Depository Shares will be delisted from Nasdaq. The text discusses the delisting determination, the appeal process, and the expected trading on alternative quotation services. There is no financial data, no detailed report, no management discussion, or other report content. The document is an official notice about the delisting event, which fits the definition of a Delisting Announcement (DLST). The document length is short (2553 characters), consistent with an announcement rather than a full report. Therefore, the correct classification is DLST with high confidence.
2009-04-16 Hebrew (modern)
Immediate Report
Delisting Announcement Classification · 98% confidence The document is an Immediate Report filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. The key content explicitly states: "Attached hereto is a report on *XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel*" and references a PDF file named *Xtlbio_DELISTING_Final_isa.pdf*. This content directly relates to the company's stock being removed from an exchange (NASDAQ). According to the definitions, the category for official notice that the company's stock will be removed from an exchange is 'Delisting Announcement' (DLST). Although it mentions an attachment, the core subject matter is the delisting notification itself, making DLST more specific than the general RPA or RNS fallback.
2009-04-16 English
Other Report or Announcement
Board/Management Information Classification · 95% confidence The document is a Form 6-K filed with the SEC, which is a report of a foreign private issuer. It includes a notification of a resignation of a co-Chief Executive Officer, which is a management change announcement. The document is short (2458 characters) and does not contain financial statements or detailed financial data. It is primarily an announcement of a management change rather than a full report or financial filing. Therefore, it fits best under the category of Board/Management Information (MANG).
2009-04-16 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 98% confidence The document is very short (1665 characters) and explicitly states that it is attaching a report filed with the SEC, specifically mentioning a "6K filed by the Company with the SEC". According to Rule 2 ('MENU VS MEAL' Rule), if a document is short and announces that a report is attached or published, it should be classified as a Report Publication Announcement (RPA). While a 6-K is a specific SEC filing, this document itself is the announcement of that filing, not the 6-K content. Since RPA is defined as an announcement regarding the publication of company reports, it is the most appropriate classification here, rather than RNS (general regulatory fallback) or trying to map 6-K to a domestic equivalent like 10-K or IR, as the document's function is purely to announce the availability of the attached report.
2009-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.